OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
May 01, 2011
Sizing Up For Success
Rising income per capita and a budding consumer health consciousness are fueling a CAGR of 9.5%, giving investors plenty of room to expand market penetration
Cloud computing is slowly but surely becoming the IT platform of choice for the industry. Pharm Exec looks at how it now affects nearly every aspect of the pharma business.
According to Eli Lilly, managing alliances requires more than good people skills
The UK coalition government's consultation on the intro of value-based pricing has invited caution and resistance
To what extent are generics companies obligated by law to request labeling changes with FDA?
Online sentiment analysis monitoring can help biopharma resource managers make crucial decisions
Why is building a successful marketing program so difficult? It should be simple, if your product is worth marketing.
Who's taken this year's top spot? Find out in Pharm Exec's annual run-down of the world's Top 50 pharma companies.
The sleek, portable iPad, coupled with customized apps, gives sales reps a leg up
Considering Big Pharma's trade objectives, the success of regional regulatory harmonization is not insignificant
Stiff price tags draw scrutiny from Congress and consumers, and raise questions about FDA policies
The EU is largely powerless when it comes to policies over pricing and reimbursement
A factory tour to examine Merck's automated robots-and the human minds that inspire them
From the Editor
What do the Pharm Exec 50 numbers tell us? The dominant theme seems to be one of gradual restructuring toward a post-patent-cliff era.
The pharmaceutical industry needs to use new and better data to accurately measure how much it is willing to invest in avoiding plan control